Biotech

Immunovative Inc. Files for Name and Symbol Change; After Necessary Approvals, Company Will Be Called: Tauriga Sciences, Inc.

NEW YORK, NY: ...

Cellceutix Signs With Leading Cancer Center for Licensing New Drug

BEVERLY, MA: ...

Dynavax Reports Fourth Quarter and Year End 2012 Financial Results

BERKELEY, CA: ...

LifeSci Advisors Announces Investment Opinion on Adherex Technologies

NEW YORK, NY: Phase II Results in Metastatic Breast Cancer Expected in Mid-2013; Report Cites Eniluracil Market Potential of $310 to $465 Million per Year; Available for Download at www.lifesciadvisors.com/clients/ ...

Medivation Reports Fourth Quarter and Year-End 2012 Financial Results and Provides Corporate Update

SAN FRANCISCO, CA: $57.4 Million in Fourth Quarter Net Sales Reflect First Full Quarter of XTANDI Sales; Conference Call Today at 4:30 p.m. Eastern Time ...

Paladin Announces Normal Course Issuer Bid and Automatic Share Purchase Plan

MONTREAL, CANADA: ...

Alchemia Completes Enrolment in Pivotal Phase III HA-Irinotecan Trial of Metastatic Colorectal Cancer

BRISBANE, AUSTRALIA: ...

Prima Biomed Commences "CANVAS" Clinical Trial in Europe

SYDNEY, AUSTRALIA: ...

PreVu(R) Skin Cholesterol Clinics Rollout Nationally

WINNIPEG, MANITOBA: Over 80 Pharmacies Preparing for Expanded Consumer Testing Across Canada ...

Avid Bioservices to Highlight Recent Successes in Reducing Manufacturing Costs and Novel Ways of Controlling Critical Process Parameters That Lead to Consistent Product Quality at IBC'S Biopharmaceutical Development and Production Conference

TUSTIN, CA and HUNTINGTON BEACH, CA: Solutions to Increase Lifetime of Purifications Resins to Decrease Production Costs; Successful Utilization of a Quality by Design (QbD) Approach to Identify Critical Process Parameters That Control C ...